Skip to main content

Advertisement

SpringerPlus
SpringerPlus Cover Image

Table 1 The tumor markers were significantly reduced during the treatment progress

From: Successful ceritinib treatment in a man with MPE and an ALK fusion gene mutation after multiple treatments

Time 8/1 8/28 9/7 10/17 11/20 12/21
CEA (ng/ml) 61.11 24.66 13.85 7.15 3.3 2.81
CA125 (U/ml) 813.8 242.9 188.1 167 102.9 89.6
Back to article page